Significant Ownership of Frazier Life Sciences X, L.P.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Frazier Life Sciences X, L.P. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Seattle, WA
- Manager signature
- /s/ Steve R. Bailey - By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P.
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Frazier Life Sciences X, L.P. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Frazier Life Sciences X, L.P.
Significant Ownership of Frazier Life Sciences X, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NAMS | NEWAMSTERDAM PHARMA COMPANY N.V. | Ordinary Shares, nominal value EUR0.12 per share | 7.7% | $245,264,825 | +$36,858,297 | 8,623,939 | +18% | Frazier Life Sciences Public Fund, L.P. | 01 Nov 2025 |
Schedules 13D/G Reported by Frazier Life Sciences X, L.P.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.